Probiotics Expand Beyond GI: Emotional Wellness Surges +160%

Executive Summary

Probiotics are accelerating penetration beyond core GI health into oral care, emotional regulation, and IBS management segments. The emotional wellness probiotic segment surged +160.2% YoY to reach CN¥ 145.6 million, driven by growing scientific evidence for gut-brain axis connections and rising mental wellness awareness. These expanded applications create high-growth opportunity zones for differentiated brand positioning as probiotics evolve into all-round health companions.

Oral Care Probiotics: Dual-Benefit Positioning

The oral care probiotics segment reached CN¥ 307.9 million with +11.8% YoY growth, benefiting from dual positioning that addresses both GI wellness and breath management. This combination appeals to professional and social scenarios where oral freshness directly impacts confidence and interactions.

Swisse dominates with 26.3% market share, followed by Earth park (19.4%) and Lactobact (4.6%). The competitive landscape shows concentrated leadership with significant opportunity for challenger brands offering differentiated formulations.

Swisse dominates oral care probiotics with 26% market share

Emotional Wellness: The Gut-Brain Axis Opportunity

The emotional wellness probiotic segment demonstrates explosive +160.2% YoY growth, reaching CN¥ 145.6 million. This growth reflects rising mental wellness awareness and consumer acceptance of microbiome-mood connections as scientific research validates gut-brain axis mechanisms.

BGI dominates with 41.8% market share through science-backed positioning that communicates the biological basis of mood-supporting probiotics. The concentrated leadership creates opportunities for science-forward brands with validated strain formulations.

BGI leads emotional probiotics at 42% share; segment grows +160% YoY

IBS Management: Specialized Segment Growth

The IBS management segment shows strong +62.2% YoY growth to reach CN¥ 43.5 million. This specialized segment features fragmented brand competition with Lifesflora leading at 14.8%, followed by Morinaga (9.3%) and g-niib (4.7%).

Clinical evidence and targeted strain formulations drive differentiation in this segment. Consumers seeking IBS solutions demonstrate higher education levels about probiotic strains and are willing to pay premiums for products with demonstrated efficacy.

Scenario-Based Consumption Patterns

Social media analysis reveals probiotics evolving from pure GI health products into all-round, scenario-based health companions. Key consumption scenarios include work environments and business travel, where portable products combining GI care and oral freshening address invisible needs for professional settings.

Work and travel scenarios lead probiotic mentions with 68K discussions each

GLP-1 Probiotic Delivery: Next-Generation Innovation

Innovative players are entering a non-pharmaceutical blue ocean by developing oral probiotic-based GLP-1 delivery systems. Genetically engineered probiotics continuously secrete GLP-1 analogs in the gut, acting as a "living drug factory" with localized, sustained release—overcoming peptide degradation while retaining oral convenience.

GLP-1 sales surge to CN¥ 290 million in Sep 2025; social buzz peaks at 77K mentions

Flavor Innovation for Mass Market Reach

Taste ranks as consumers' third most important consideration after efficacy and side effects. Products that cannot deliver pleasant taste experiences face competitive disadvantage in reaching mass markets. Probiotic snacks represent the key track for reaching young consumers, solving inconvenient intake and poor taste issues.

Successful flavor innovations include:

• Combinations with superfoods and trendy flavors
• Probiotic condiments and ice cream formats
• Glico's probiotic cookies receiving high ratings for taste and texture
• Probiotics as value-add rather than core product perception

Key Takeaways

• Emotional wellness probiotics surged +160% YoY to CN¥ 145.6 million
• Oral care probiotics reached CN¥ 307.9 million with Swisse leading at 26% share
• Work and travel scenarios drive 68K social media mentions each
• GLP-1 probiotic delivery systems represent next-generation innovation opportunity
• Flavor optimization is critical for mass market penetration

About the Data

This analysis draws on Moojing Market Intelligence data covering Jan-Sep 2025. Moojing tracks 400,000+ brands across 30+ e-commerce platforms, representing 58-65% of China's online retail GMV. For full methodology and additional insights, see the complete GI Health Supplements whitepaper.